Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms

被引:58
|
作者
Kohtala, Samuel [1 ,2 ,3 ]
机构
[1] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Drug Res Program, Lab Neurotherapeut,Fac Pharm, POB 56, Helsinki 00014, Finland
[2] Univ Helsinki, SleepWell Res Program, Fac Med, Helsinki, Finland
[3] Weill Cornell Med, Dept Psychiat, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA
关键词
Ketamine; Subanesthetic; Rapid-acting antidepressant; Depression; Dose; Anesthesia; TREATMENT-RESISTANT DEPRESSION; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; D-ASPARTATE ANTAGONIST; PHANTOM LIMB PAIN; DOUBLE-BLIND; INTRAVENOUS KETAMINE; SUBANESTHETIC KETAMINE; ORAL ANTIDEPRESSANT; DOSE KETAMINE;
D O I
10.1007/s43440-021-00232-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. More recently, ketamine has been studied and used for several new indications, ranging from chronic pain to drug addiction and post-traumatic stress disorder. The discovery of the rapid-acting antidepressant effects of ketamine has resulted in a surge of interest towards understanding the precise mechanisms driving its effects. Indeed, ketamine may have had the largest impact for advancements in the research and treatment of psychiatric disorders in the past few decades. While intense research efforts have been aimed towards uncovering the molecular targets underlying ketamine's effects in treating depression, the underlying neurobiological mechanisms remain elusive. These efforts are made more difficult by ketamine's complex dose-dependent effects on molecular mechanisms, multiple pharmacologically active metabolites, and a mechanism of action associated with the facilitation of synaptic plasticity. This review aims to provide a brief overview of the different uses of ketamine, with an emphasis on examining ketamine's rapid antidepressant effects spanning molecular, cellular, and network levels. Another focus of the review is to offer a perspective on studies related to the different doses of ketamine used in antidepressant research. Finally, the review discusses some of the latest hypotheses concerning ketamine's action.
引用
收藏
页码:323 / 345
页数:23
相关论文
共 50 条
  • [41] Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
    Le, Tuyen T.
    Di Vincenzo, Joshua D.
    Teopiz, Kayla M.
    Lee, Yena
    Cha, Danielle S.
    Lui, Leanna M. W.
    Rodrigues, Nelson B.
    Ho, Roger C.
    Cao, Bing
    Lin, Kangguang
    Nasri, Flora
    Gill, Hartej
    Lipsitz, Orly
    Subramaniapillai, Mehala
    Mansur, Rodrigo B.
    Rosenblat, Joshua D.
    McIntyre, Roger S.
    PSYCHIATRY RESEARCH, 2021, 306
  • [42] The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways
    Ren, Li
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2024, 129
  • [43] Neurobiological mechanisms for the antidepressant effects of mind-body and physical exercises: A systematic review
    Sun, Wen
    Lu, Erin Yiqing
    Wang, Cong
    Tsang, Hector Wing Hong
    MENTAL HEALTH AND PHYSICAL ACTIVITY, 2023, 25
  • [44] Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant Effects
    Feifel, David
    DRUG DEVELOPMENT RESEARCH, 2016, 77 (08) : 489 - 494
  • [45] Maintaining Rapid Antidepressant Effects Following Ketamine Infusion: A Major Unmet Need
    Papakostas, George, I
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (02)
  • [46] Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine
    Deyama, Satoshi
    Bang, Eunyoung
    Wohleb, Eric S.
    Li, Xiao-Yuan
    Kato, Taro
    Gerhard, Danielle M.
    Dutheil, Sophie
    Dwyer, Jason M.
    Taylor, Seth R.
    Picciotto, Marina R.
    Duman, Ronald S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (05): : 388 - 400
  • [47] Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
    Yang, Chun
    Yang, Jianjun
    Luo, Ailin
    Hashimoto, Kenji
    TRANSLATIONAL PSYCHIATRY, 2019, 9 (1)
  • [48] Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
    Browne, Caroline A.
    Lucki, Irwin
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [49] Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
    Chun Yang
    Jianjun Yang
    Ailin Luo
    Kenji Hashimoto
    Translational Psychiatry, 9
  • [50] Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
    Johnston, Jenessa N.
    Kadriu, Bashkim
    Allen, Josh
    Gilbert, Jessica R.
    Henter, Ioline D.
    Zarate, Carlos A., Jr.
    NEUROPHARMACOLOGY, 2023, 226